SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-093276
Filing Date
2021-03-25
Accepted
2021-03-25 06:09:59
Documents
3
Period of Report
2021-03-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d161791d8k.htm 8-K 18070
2 EX-99.1 d161791dex991.htm EX-99.1 51383
3 GRAPHIC g161791g0324225346109.jpg GRAPHIC 3615
  Complete submission text file 0001193125-21-093276.txt   75813
Mailing Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210
Business Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210 857-330-4340
Inozyme Pharma, Inc. (Filer) CIK: 0001693011 (see all company filings)

IRS No.: 475129768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39397 | Film No.: 21770035
SIC: 2834 Pharmaceutical Preparations